Paroxetine 37.5 mg Prolonged Release Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Paroxetine 37.5 mg Prolonged Release Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: SSRI Prolonged Release
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Paroxetine 37.5 mg Prolonged Release Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Paroxetine 37.5 mg Prolonged Release Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Paroxetine 37.5 mg Prolonged Release Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Paroxetine 37.5 mg Prolonged Release formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Major depressive disorder
- Panic disorder
- PTSD
- Patients with GI sensitivity to immediate release
Mechanism of Action
Paroxetine is an SSRI antidepressant — selectively inhibits presynaptic serotonin reuptake (SERT). Also has mild anticholinergic and noradrenergic reuptake inhibition. Effective in depression, anxiety disorders, PMDD, OCD, PTSD. Highest discontinuation symptoms among SSRIs due to short half-life and active metabolites.
Dosage & Administration
- Adults: 37.5 mg PR once daily.
Side Effects
- Nausea, sexual dysfunction (most common SSRI), weight gain, discontinuation syndrome (significant), drowsiness, dry mouth (anticholinergic).
Contraindications
- MAO inhibitor use (within 14 days), pregnancy (cardiac malformations — Category D), thioridazine, severe hepatic impairment.
Storage
Store below 30 °C in a dry place, protected from light and moisture.
PCD Pharma Franchise for Paroxetine 37.5 mg Prolonged Release Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 10 (Alu Alu)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Paroxetine 37.5 mg Prolonged Release Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Paroxetine 37.5 mg Prolonged Release Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Paroxetine 37.5 mg Prolonged Release Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Paroxetine 37.5 mg Prolonged Release Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Paroxetine 37.5 mg Prolonged Release Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Paroxetine 37.5 mg Prolonged Release Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Paroxetine 37.5 mg Prolonged Release Tablet?
Available pack sizes include: 10 x 10 (Alu Alu).
What is the MRP / trade price for Paroxetine 37.5 mg Prolonged Release Tablet?
MRPs range from ₹2990 to ₹2990 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Paroxetine 37.5 mg Prolonged Release Tablet?